Trial Profile
Prospective analysis to predict the prognosis of hepatocellular carcinoma patients who were treated with sorafenib
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Aug 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 13 Aug 2015 New trial record